263 related articles for article (PubMed ID: 34650049)
1. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
[TBL] [Abstract][Full Text] [Related]
2. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway.
Li H; Zhang Y; Hai J; Wang J; Zhao B; Du L; Geng X
Biomed Pharmacother; 2018 Jul; 103():1272-1278. PubMed ID: 29864908
[TBL] [Abstract][Full Text] [Related]
4. TRIM45 functions as a tumor suppressor in the brain via its E3 ligase activity by stabilizing p53 through K63-linked ubiquitination.
Zhang J; Zhang C; Cui J; Ou J; Han J; Qin Y; Zhi F; Wang RF
Cell Death Dis; 2017 May; 8(5):e2831. PubMed ID: 28542145
[TBL] [Abstract][Full Text] [Related]
5. Nickel chloride promotes lung cancer invasion and metastasis by up-regulating the expression of E3 ubiquitin ligase TRIM31 through the IL-6/STAT3 signaling axis.
Lu Y; Su F; Cheng Z; Yang J; Dai H; Yang J; Zhang T; Bai Y
Life Sci; 2023 Nov; 332():122111. PubMed ID: 37734436
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
Xu C; Fan CD; Wang X
Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
[TBL] [Abstract][Full Text] [Related]
7. Tripartite motif 31 promotes resistance to anoikis of hepatocarcinoma cells through regulation of p53-AMPK axis.
Guo P; Qiu Y; Ma X; Li T; Ma X; Zhu L; Lin Y; Han L
Exp Cell Res; 2018 Jul; 368(1):59-66. PubMed ID: 29665353
[TBL] [Abstract][Full Text] [Related]
8. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑29c‑3p acts as a tumor suppressor gene and inhibits tumor progression in hepatocellular carcinoma by targeting TRIM31.
Lv T; Jiang L; Kong L; Yang J
Oncol Rep; 2020 Mar; 43(3):953-964. PubMed ID: 32020206
[TBL] [Abstract][Full Text] [Related]
10. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37.
Ge Y; Zhao R; Li B; Xiao B; Zhou L; Zuo S
Exp Cell Res; 2022 Dec; 421(2):113377. PubMed ID: 36252649
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.
Zhao K; Yang Y; Zhang G; Wang C; Wang D; Wu M; Mei Y
EMBO Rep; 2018 Feb; 19(2):305-319. PubMed ID: 29295817
[TBL] [Abstract][Full Text] [Related]
12. Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187.
Li X; Niu Z; Sun C; Zhuo S; Yang H; Yang X; Liu Y; Yan C; Li Z; Cao Q; Ji G; Ding Y; Zhuang T; Zhu J
Cell Death Dis; 2022 Feb; 13(2):149. PubMed ID: 35165289
[TBL] [Abstract][Full Text] [Related]
13. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling.
Zheng D; Ning J; Deng H; Ruan Y; Cheng F
J Transl Med; 2024 May; 22(1):481. PubMed ID: 38773612
[TBL] [Abstract][Full Text] [Related]
14. Regulation of p53 level by UBE4B in breast cancer.
Zhang Y; Lv Y; Zhang Y; Gao H
PLoS One; 2014; 9(2):e90154. PubMed ID: 24587254
[TBL] [Abstract][Full Text] [Related]
15. The E3 ubiquitin ligase TRIM31 plays a critical role in hypertensive nephropathy by promoting proteasomal degradation of MAP3K7 in the TGF-β1 signaling pathway.
Zhang J; Cao L; Wang X; Li Q; Zhang M; Cheng C; Yu L; Xue F; Sui W; Sun S; Li N; Bu P; Liu B; Gao F; Zhen J; Su G; Zhang C; Gao C; Zhang M; Zhang Y
Cell Death Differ; 2022 Mar; 29(3):556-567. PubMed ID: 34584221
[TBL] [Abstract][Full Text] [Related]
16. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.
Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J
Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778
[TBL] [Abstract][Full Text] [Related]
17. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
18. TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation.
Ma X; Ma X; Qiu Y; Zhu L; Lin Y; You Y; Ma D; Qin Z; Sun C; Zhao Y; Sun Y; Han L
Cell Death Dis; 2018 May; 9(6):608. PubMed ID: 29789583
[TBL] [Abstract][Full Text] [Related]
19. Sequential ubiquitination of p53 by TRIM28, RLIM, and MDM2 in lung tumorigenesis.
Jin JO; Lee GD; Nam SH; Lee TH; Kang DH; Yun JK; Lee PC
Cell Death Differ; 2021 Jun; 28(6):1790-1803. PubMed ID: 33328571
[TBL] [Abstract][Full Text] [Related]
20. Tripartite motif-containing protein 6 facilitates growth and migration of breast cancer through degradation of STUB1.
Wei C; Wu J; Liu W; Lu J; Li H; Hai B
Eur J Histochem; 2021 Mar; 65(1):. PubMed ID: 33728863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]